Log in to search using one of your social media accounts:

 

Space station project seeks to crystalize the means to counteract nerve poisons

(NIH/National Institute of Neurological Disorders and Stroke) The microgravity conditions of the International Space Station (ISS) may hold the key to improving our understanding of how to combat toxic nerve agents such as sarin and VX. That is the hope of Countermeasures Against Chemical Threats (CounterACT) project that is part of an initiative at the National Institutes of Health aimed at developing improved antidotes for chemical agents.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news

Related Links:

Authors: Maher A, Abdel Rahman MF, Gad MZ Abstract Until the beginning of the 1980s, nitric oxide (NO) was just a toxic molecule of a lengthy list of environmental pollutants such as cigarette smoke and smog. In fact, NO had a very bad reputation of being destroyer of ozone, suspected carcinogen and precursor of acid rain. However, by the early 1990s it was well recognized by the medical research community. Over the last two decades, the picture has been totally changed. Diverse lines of evidence have converged to show that this sometime poison is a fundamental player in the everyday business of the human body. NO ...
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
Conclusion: To address the many challenges posed by EDCs, we argue that Africans should take the lead in prioritization and evaluation of environmental hazards, including EDCs. We recommend the institution of education and training programs for chemical users, adoption of the precautionary principle, establishment of biomonitoring programs, and funding of community-based epidemiology and wildlife research programs led and funded by African institutes and private companies. https://doi.org/10.1289/EHP1774 Received: 16 February 2017 Revised: 22 May 2017 Accepted: 24 May 2017 Published: 22 August 2017 Address correspond...
Source: EHP Research - Category: Environmental Health Authors: Tags: Commentary Source Type: research
(NIH/National Institute of Neurological Disorders and Stroke) The microgravity conditions of the International Space Station (ISS) may hold the key to improving our understanding of how to combat toxic nerve agents such as sarin and VX. That is the hope of Countermeasures Against Chemical Threats (CounterACT) project that is part of an initiative at the National Institutes of Health aimed at developing improved antidotes for chemical agents.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
An experimental antiplatelet drug has surprising bite. Based on a protein found in snake venom, the new drug prevented blood clotting in mice without causing excessive bleeding after an injury, according to research published Thursday in the journal Arteriosclerosis, Thrombosis and Vascular Biology. The drug has yet to be tested in humans.Bleeding is a common side effect in the current crop of available antiplatelet drugs, which are usually prescribed for heart patients to prevent blood cells, called platelets, from clumping together and forming clots. Depending on where they occur, clots can lead to a stroke or heart atta...
Source: Medical Hemostat - Category: Medical Devices Authors: Source Type: blogs
View Original Article Here: Nursing Home Signs You May Not Be Noticing As the population ages, more family members find themselves taking care of elderly parents, grandparents or other loved ones. It can be difficult to care for loved ones while working, caring for your children, and keeping up with social commitments. You will likely arrive at a crossroads where you’re forced to ask “when is it time for assisted living?” While many family members do not want to consider committing their loved ones to an institution like an assisted living facility or a nursing home, it isn’t always possible to mov...
Source: Shield My Senior - Category: Geriatrics Authors: Tags: Senior Safety Source Type: blogs
Temperatures were in the 100s when Vanessa Dunn, a 29-year-old Los Angeles-based makeup artist, was driving back home to California from Virginia last summer. After hours on the road and drinking limited water, she was struck by a severe case of dehydration and heat stroke. ”I wasn’t drinking enough water because I didn’t want to stop to pee,” she says. When she finally pulled over for the night she felt light-headed, and she couldn’t keep food down when she tried to eat. She even threw up blood. ”I was in incredible pain, and dizzy,” she says. “[I went] to the ER, turned out...
Source: Science - The Huffington Post - Category: Science Source Type: news
Why did my brother warn me against reading this book? It’s so good! I thought to myself, as I quickly devoured the pages of JoJo Moyes bestseller titled Me Before You. It was an uplifting tale about a young man who rediscovers love and laughter after a devastating spinal cord injury left him in a dangerous pool of depression. Finding myself at times in my own, albeit more shallow, pool of depression, I knew this story was exactly what I needed to remind me that I could find meaning in my life after my stroke. As I continued reading, anticipating the feel-good happy ending with a girl saving the boy's life with the po...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
We have to talk about drugs. No, not illicit drugs, but medications used by doctors and patients. Plaintiff attorneys run ads on TV that fool people into thinking certain meds are bad. The current one I deal with is the clot-blocking drug rivaroxaban (Xarelto.) Before that, it was dabigatran (Pradaxa). If, or when, the makers of rivaroxaban settle a class action suit, you can bet apixaban (Eliquis) will be next. These ads are a problem because they use fear persuasion (see Scott Adams’ blog), and because they can induce patients to stop taking or not starting a beneficial medicine.  Lots of other medications suf...
Source: Dr John M - Category: Cardiology Authors: Source Type: blogs
CONCLUSIONS: HBOT is associated with a lower mortality rate in patients with COP, especially in those who were younger than 20 years and those with acute respiratory failure. The results provide important references for decision making in the treatment of COP. PMID: 28427969 [PubMed - as supplied by publisher]
Source: Chest - Category: Respiratory Medicine Authors: Tags: Chest Source Type: research
This study assessed the prevalence of grey hair in patients with coronary artery disease and whether it was an independent risk marker of disease. This was a prospective, observational study which included 545 adult men who underwent multi-slice computed tomography (CT) coronary angiography for suspected coronary artery disease. Patients were divided into subgroups according to the presence or absence of coronary artery disease, and the amount of grey/white hair. The amount of grey hair was graded using the hair whitening score: 1 = pure black hair, 2 = black more than white, 3 = black equals white, 4 = white more t...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
More News: Brain | Chemistry | International Medicine & Public Health | National Institutes of Health (NIH) | Neurology | Poisoning | Stroke | Toxicology